Related Experiment Video
Updated: Jul 29, 2026
06:58
Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
Published on: June 25, 2016
Single dose phenobarbitone prevents convulsions in cerebral malaria
N J White1, S Looareesuwan, R E Phillips
1Bangkok Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Thailand.
Lancet (London, England)
|July 9, 1988
Summary
A single phenobarbitone injection effectively prevents convulsions in children with cerebral malaria. This simple, cost-effective treatment significantly reduced seizure incidence without adverse effects in a clinical trial.
Area of Science:
- Pediatric Neurology
- Infectious Diseases
- Clinical Pharmacology
Background:
- Cerebral malaria is a severe complication of malaria, particularly in children.
- Convulsions are a common and dangerous neurological manifestation of cerebral malaria.
Purpose of the Study:
- To evaluate the efficacy of a single intramuscular phenobarbitone injection in preventing subsequent convulsions in pediatric patients with cerebral malaria.
Main Methods:
- A double-blind, placebo-controlled study involving 48 pediatric patients (age >6 years) with strictly defined cerebral malaria.
- Patients received either a single intramuscular injection of phenobarbitone (3.5 mg/kg) or a placebo.
Main Results:
- Phenobarbitone significantly reduced the incidence of subsequent convulsions from 54% in the placebo group to 12.5% in the phenobarbitone group.
- No adverse effects were reported with the single intramuscular phenobarbitone injection.
Conclusions:
- A single intramuscular injection of phenobarbitone is a safe, effective, and simple method for preventing convulsions in cerebral malaria.
- This intervention offers a low-cost strategy to mitigate a severe neurological complication in pediatric malaria.
Related Concept Videos
01:20Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...